Abstract

Immune thrombocytopenia (ITP) is an autoimmune disorder, in which megakaryocyte dysfunction caused by an autoimmune reaction can lead to thrombocytopenia, although the underlying mechanisms remain unclear. Here, we performed single-cell transcriptome profiling of bone marrow CD34+ hematopoietic stem and progenitor cells (HSPCs) to determine defects in megakaryopoiesis in ITP. Gene expression, cell-cell interactions, and transcriptional regulatory networks varied in HSPCs of ITP, particularly in immune cell progenitors. Differentially expressed gene (DEG) analysis indicated that there was an impaired megakaryopoiesis of ITP. Flow cytometry confirmed that the number of CD9+ and HES1+ cells from LinCD34+CD45RA HSPCs decreased in ITP. Liquid culture assays demonstrated that CD9+LinCD34+CD45RA HSPCs tended to differentiate into megakaryocytes; however, this tendency was not observed in ITP patients and more erythrocytes were produced. The percentage of megakaryocytes differentiated from CD9+LinCD34+CD45RA HSPCs was 3-fold higher than that of the CD9 counterparts from healthy controls (HCs), whereas, in ITP patients, the percentage decreased to only 1/4th of that in the HCs and was comparable to that from the CD9 HSPCs. Additionally, when co-cultured with pre-B cells from ITP patients, the differentiation of CD9+LinCD34+CD45RA HSPCs toward the megakaryopoietic lineage was impaired. Further analysis revealed that megakaryocytic progenitors (MkP) can be divided into seven subclusters with different gene expression patterns and functions. The ITP-associated DEGs were MkP subtype-specific, with most DEGs concentrated in the subcluster possessing dual functions of immunomodulation and platelet generation. This study comprehensively dissects defective hematopoiesis and provides novel insights regarding the pathogenesis of ITP.

Details

Title
Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia
Author
Liu, Yan 1 ; Zuo, Xinyi 2 ; Chen, Peng 1 ; Hu, Xiang 3 ; Sheng, Zi 3 ; Liu, Anli 3 ; Liu, Qiang 3 ; Leng, Shaoqiu 3 ; Zhang, Xiaoyu 3 ; Li, Xin 3 ; Wang, Limei 4 ; Feng, Qi 5 ; Li, Chaoyang 6 ; Hou, Ming 7 ; Chu, Chong 8 ; Ma, Shihui 9 ; Wang, Shuwen 5 ; Peng, Jun 10   VIAFID ORCID Logo 

 Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); the Affiliated Hospital of Qingdao University, Department of Hematology, Qingdao, China (GRID:grid.412521.1) (ISNI:0000 0004 1769 1119) 
 Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Shandong University, Advanced Medical Research Institute, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Shandong University, Shangdong Key Laboratory of Immunochematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Shandong University, Shangdong Key Laboratory of Immunochematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Shandong University, Shangdong Key Laboratory of Immunochematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Shandong University, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 Harvard Medical School, Department of Biomedical Informatics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
10  Shandong University, Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Shandong University, Advanced Medical Research Institute, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
ISSN
20959907
e-ISSN
20593635
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2722024253
Copyright
© The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.